World Health Summit – Personalities
Nobel Prize Laureat and Director of the Regulation of Retroviral Infections at the Institute Pasteur in Paris
Francoise Barré Sinoussi won the Nobel Prize for Medicine in 2008 for her role in the discovery of HIV. She is the Director of the Regulation of Retroviral Infections, at the Institute Pasteur in Paris. The research programs of her team are focused on models of protection against HIV/AIDS. Along with her research activities, she has been implicated in promoting integration between HIV/AIDS research and action in resource limited countries.
Francoise Barré-Sinoussi will speak in the Key Note Lectures on October 12th, 2010, 15.00 – 16.00 (Main Hall) about “Translational Research, A Vital Component for Global Health Improvement: The Example of HIV/AIDS “.
Sessions at the World Health Summit
Working Session “The Efficiency Challenge: Improving Quality and Productivity in Health Care”
How can we improve the quality of healthcare and still control the costs?
On a global scale, healthcare costs have risen by 2 percent more than inflation over the past 50 years. A number of factors, specific to developed countries will increase costs even further. We have to look at an aging population. The population will change significantly towards older citizens. The elderly account for a substantial share of health and social care costs. We also observe a growth in long-term chronic diseases like coronary heart diseases, depression and adult obesity.
>> read more
Working Session on October 11th, 2010, 10:30-12:30, Session Room “Koch”
World Health Summit Network
The M8 Alliance and its Members:
Monash University of Melbourne
The university is continually evolving and has worked its way up within a few years to be one of the 50 best universities in the world (Times Higher Education Survey). To date, 75 research centers associated with the university have been developed, not just in Australia itself but also in Europe (Great Britain and Italy). International and intercultural competences in terms of long-term work in institutions with close links – the university seems to have been brought up with this concept, as it was founded with the motto “ancora imparo” (I am still learning).
Improved Global Health – New Products for Developing Countries
Research for Health Goods in Developing Countries is Needed.
Every day 35,000 deaths are caused by neglected diseases in low and middle income countries. These diseases are associated with poverty and are thus known as poverty-related diseases. The developing world is primarily affected by these diseases, which include malaria, tuberculosis, certain aspects of HIV/AIDS, leprosy and many others. One reason for the affection of the world’s poorest is that effective medical treatment is not available, accessible and affordable for those in need. Due to the fact that people in low and middle income countries do not constitute lack purchasing power, research and development of diagnostics, prevention technologies and treatment for neglected diseases do not constitute a focus of the private pharmaceutical industry’s research portfolios. This imbalance is also called the “10/90 Gap”, which refers to the fact that only 10% of worldwide expenditure on health and research and development is devoted to the problems that primarily affect the poorest 90% of the world's population.
DSW is organizing a Partner Symposium on “Product Development Partnership (PDP) Research for Health Goods in Developing Countries”. The session takes place on Sunday, October 10th 2010, 14.30 – 16.00 in session room “Langenbeck”.
Sorbonne Paris Cité participates in the second World Health Summit
Sorbonne Paris Cité was the first Alliance for Research and Higher Education founded in Paris by decree of February 10, 2010. It combines eight universities and institutes with 120,000 students: New Sorbonne University, Paris Descartes University, Paris Diderot University, Paris 13 University, Institute of Earth Physics of Paris, National Institute of Oriental Languages and Civilizations, Sciences Po and EHESP School of Public Health.
It is well-known that the global population is aging rapidly, owing largely to falling fertility rates and increasing life spans. By 2050, the number of older people (aged 60 years or above) in the world will exceed the number of children (under 15 years of age) for the first time in history. Older people have complex healthcare requirements, which affect the cost and demand of healthcare services. Indeed, people’s demand for healthcare is mostly concentrated at the beginning of life (under 1 year old) and at the end, when people typically consume 80 percent of the entire healthcare they will require over their lifetime. Within this context of demand, the healthcare industry is already suffering from a workforce shortage, and the rapid increase in the aging population will create additional pressure on the healthcare systems.
Empowering Women by Improving Reproductive Health
Every year 14 million teenage women aged 15 to 19 give birth to a child with more than 90% of them living in developing countries. Here, the concept of family planning has been mostly unheard of and contraceptives are not readily available. Either they are too expensive or completely unknown. As a result, according to the annual report of the German Foundation for World Population (DSW), about 76 million women in developing countries have unwanted pregnancies every year. Complications during pregnancy, birth or abortion result in half a million deaths per year. Other women suffer poverty or health problems as a result of having unplanned children.
World Health Summit Contact
World Health Summit Secretariat
c/o K.I.T Group GmbH
Association & Conference Management Group
Kurfürstendamm 71, 10709 Berlin
Tel.: +49 30 246 03 240